Anita Brikman/thefemword.world
Jul 21, 2026, 00:55
Anita Brikman on PPTA’s First-Half 2026 Achievements
Plasma Protein Therapeutics Association (PPTA) shared on LinkedIn:
”As 2026 reaches its midpoint, PPTA and its members have made significant progress in strengthening patient access to plasma-derived therapies worldwide.
From advancing advocacy efforts in North America and Europe to expanding global stakeholder engagement and supporting important regulatory initiatives, the first half of the year has demonstrated the power of collaboration across the plasma community.
Watch as PPTA President and CEO Anita Brikman reflects on key achievements from the first six months of 2026, then read the full report.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026